Profit taking sinks KaloBios By: MarketMinute.com Stock News November 24, 2015 at 17:56 PM EST Investors locked in profits on KaloBios Pharmaceuticals Inc. (Nasdaq: KBIO). The stock price plummeted $21.10 to close at $18.40.